L-Dihydroorotic Acid Crystal Habit & Dissolution Kinetics
Crystal Habit Engineering of L-Dihydroorotic Acid: Needle vs. Prismatic Morphologies via Cooling Rate Control
In the synthesis of L-Dihydroorotic Acid, also known as (S)-Dihydroorotic Acid or (4S)-2,6-Dioxohexahydro-4-pyrimidinecarboxylic Acid, the crystallization step is pivotal in determining the final crystal habit. Our manufacturing process at NINGBO INNO PHARMCHEM leverages precise cooling rate control to produce either needle-shaped or prismatic morphologies. Needle-like crystals, often obtained through rapid cooling, exhibit a high aspect ratio and can present challenges in filtration and flowability. Conversely, a controlled slow cooling profile yields more equant, prismatic crystals that are preferred for downstream processing. This is not merely an academic exercise; the crystal habit directly influences the dissolution kinetics, which is critical when formulating diagnostic reagents where consistent solubility is paramount. For procurement managers, understanding that we can tailor the crystal habit to your specific formulation needs—without altering the chemical identity—is a key advantage. We have observed that in some batches, trace impurities from the synthesis route can act as habit modifiers, subtly shifting the morphology. Our quality control monitors this closely, and we recommend referencing the batch-specific COA for detailed habit characterization. For applications requiring high surface area, such as in DHODH inhibitor screening, the needle habit may be advantageous, as discussed in our article on bulk L-Dihydroorotic Acid for DHODH inhibitor screening with inert atmosphere packaging.
Dissolution Kinetics in Aqueous Diagnostic Buffers: Impact of Crystal Habit on Solubility and Rate-Limiting Steps
When L-Dihydroorotic Acid is employed in diagnostic reagent formulations, its dissolution rate in aqueous buffers often becomes the rate-limiting step for assay performance. Drawing from field experience, we have noted that needle-shaped crystals of (S)-Dihydroorotic Acid typically dissolve faster than their prismatic counterparts due to a higher specific surface area and a greater proportion of high-energy crystal faces exposed to the solvent. However, this is not a linear relationship; at sub-zero temperatures, we have observed a non-standard parameter: a viscosity shift in the dissolution medium that can retard the dissolution of fine needles, leading to agglomeration and inconsistent kinetics. This edge-case behavior is critical for reagents stored or used in cold-chain logistics. For procurement managers, the choice of crystal habit should align with the intended buffer system and temperature profile. Our product, a drop-in replacement for Sigma-Aldrich D7128, as detailed in our comparison with Sigma-Aldrich D7128, offers equivalent purity and can be seamlessly integrated into existing protocols. We ensure that the dissolution profile is consistent batch-to-batch by controlling the crystallization parameters, but we always advise customers to perform a small-scale compatibility test, especially when transitioning from another supplier.
Particle Size Distribution and Assay Consistency: Ensuring Reagent Homogeneity in High-Throughput Screening
In high-throughput screening (HTS) environments, the particle size distribution (PSD) of L-Dihydroorotic Acid is as crucial as its chemical purity. A narrow PSD ensures uniform dissolution and minimizes variability in assay results. Our industrial manufacturing process yields a consistent PSD, typically with a D90 below 100 µm, but we can adjust milling parameters to meet tighter specifications. However, over-milling can induce amorphization or create fines that lead to caking, a non-standard behavior we have mitigated through optimized jet milling under controlled humidity. For diagnostic reagent formulation, where L-Dihydroorotic Acid serves as a substrate or inhibitor, lot-to-lot consistency in PSD is non-negotiable. We provide detailed COA data including PSD by laser diffraction. The table below compares typical specifications for our standard and fine-milled grades:
| Parameter | Standard Grade (STD) | Fine-Milled Grade (FM) |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | ≥ 99.0% |
| Particle Size (D90) | ≤ 100 µm | ≤ 50 µm |
| Polymorph | Form I (confirmed by PXRD) | Form I (confirmed by PXRD) |
| Bulk Density | 0.5–0.7 g/mL | 0.3–0.5 g/mL |
| Residual Solvents | Complies with USP <467> | Complies with USP <467> |
Please refer to the batch-specific COA for exact values. Our commitment to quality ensures that each shipment of (S)-2,6-Dioxohexahydro-4-pyrimidinecarboxylic Acid meets the stringent requirements of global diagnostic manufacturers.
Technical Specifications and COA Parameters for Bulk L-Dihydroorotic Acid: Purity, Polymorphism, and Packaging
For bulk procurement of L-Dihydroorotic Acid (CAS 5988-19-2), the key technical parameters extend beyond simple purity. Our product is consistently manufactured to a minimum purity of 99.0% by HPLC, with the major polymorph being the thermodynamically stable Form I. Polymorphism control is critical because different crystal forms can exhibit vastly different dissolution rates and stability profiles. We confirm polymorphic identity by powder X-ray diffraction (PXRD) for every batch. Other COA parameters include water content (Karl Fischer), residue on ignition, and heavy metals. From a logistics standpoint, we offer standard packaging in 25 kg fiber drums with double PE liners, and for larger quantities, 210L drums or IBC totes are available. The packaging is designed to protect the product from moisture and physical damage during transit. We do not claim any specific environmental certifications, but our packaging complies with international shipping standards. For procurement managers seeking a reliable global manufacturer, our industrial purity L-Dihydroorotic Acid offers a cost-effective solution without compromising on quality. The synthesis route is optimized for scalability, ensuring a stable supply and competitive bulk price.
Frequently Asked Questions
What are the typical milling requirements for L-Dihydroorotic Acid to achieve a specific particle size?
Milling requirements depend on the target particle size and the initial crystal habit. For needle-shaped crystals, gentle de-agglomeration may suffice, while prismatic crystals often require jet milling. We can provide material milled to your specifications; please inquire with your desired D90.
How does the viscosity of common diagnostic buffers affect the dissolution of L-Dihydroorotic Acid?
Buffer viscosity can significantly impact dissolution, especially at low temperatures. Higher viscosity reduces the diffusion coefficient, slowing dissolution. We have observed that in phosphate-buffered saline (PBS) at 4°C, the dissolution rate of our standard grade decreases by approximately 20% compared to room temperature. Pre-warming the buffer or using a fine-milled grade can mitigate this.
What is the shelf-life stability of L-Dihydroorotic Acid under ambient storage conditions?
When stored in its original, unopened packaging at controlled room temperature (20–25°C) and protected from light and moisture, L-Dihydroorotic Acid is stable for at least 24 months. We recommend retesting after this period. Avoid exposure to high humidity, as the compound is slightly hygroscopic.
Can you provide L-Dihydroorotic Acid with a specific polymorphic form?
Our standard product is Form I, which is the most stable polymorph. If you require a different polymorph, please contact our technical team to discuss feasibility. We can attempt to isolate other forms through customized crystallization, but this would require a development agreement.
Is your L-Dihydroorotic Acid suitable as a drop-in replacement for other commercial sources?
Yes, our product is designed to be a seamless drop-in replacement for major suppliers, including Sigma-Aldrich D7128. It meets or exceeds the purity specifications and exhibits comparable dissolution behavior. We recommend a small-scale qualification to confirm compatibility with your specific formulation.
Sourcing and Technical Support
At NINGBO INNO PHARMCHEM, we understand that sourcing high-quality L-Dihydroorotic Acid for diagnostic reagent formulation requires more than just a competitive bulk price. Our technical team is ready to support you with detailed COA data, polymorph characterization, and advice on crystal habit selection to optimize your dissolution kinetics. Whether you need standard or fine-milled grades, we ensure supply chain reliability with robust packaging options. For more information, visit our product page: L-Dihydroorotic Acid high purity pharmaceutical intermediate. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.